These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 12410533)

  • 1. Nasopharyngeal carcinoma in situ (NPCIS)--pathologic and clinical perspectives.
    Pak MW; To KF; Lo YM; Chan LY; Tong JH; Lo KW; van Hasselt CA
    Head Neck; 2002 Nov; 24(11):989-95. PubMed ID: 12410533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasopharyngeal carcinoma in situ: two cases of an emerging diagnostic entity.
    Cheung F; Pang SW; Hioe F; Cheung KN; Lee A; Yau TK
    Cancer; 1998 Sep; 83(6):1069-73. PubMed ID: 9740069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo real-time diagnosis of nasopharyngeal carcinoma in situ by contact rhinoscopy.
    Wai Pak M; To KF; Lee JC; Liang EY; van Hasselt CA
    Head Neck; 2005 Nov; 27(11):1008-13. PubMed ID: 16134185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
    Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
    Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
    Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
    Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma.
    Twu CW; Wang WY; Liang WM; Jan JS; Jiang RS; Chao J; Jin YT; Lin JC
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):130-7. PubMed ID: 16979842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity and specificity of Epstein-Barr virus IGA titer in the diagnosis of nasopharyngeal carcinoma: a three-year institutional review.
    Tsang RK; Vlantis AC; Ho RW; Tam JS; To KF; van Hasselt CA
    Head Neck; 2004 Jul; 26(7):598-602. PubMed ID: 15229902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of patients with positive Epstein-Barr virus serologic status in the absence of nasopharyngeal carcinoma in Hong Kong.
    Lo S; Ho WK; Wei WI
    Arch Otolaryngol Head Neck Surg; 2004 Jun; 130(6):770-2. PubMed ID: 15210561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma.
    Chang KP; Hsu CL; Chang YL; Tsang NM; Chen CK; Lee TJ; Tsao KC; Huang CG; Chang YS; Yu JS; Hao SP
    Oral Oncol; 2008 Aug; 44(8):784-92. PubMed ID: 18206420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of EBV and HPV in nasopharyngeal carcinoma by in situ hybridization.
    Mirzamani N; Salehian P; Farhadi M; Tehran EA
    Exp Mol Pathol; 2006 Dec; 81(3):231-4. PubMed ID: 16787643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
    Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y
    Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Epstein-Barr virus DNA in serum of patients with lymphoepithelioma-like carcinoma of the lung: a potential surrogate marker for monitoring disease.
    Ngan RK; Yip TT; Cheng WW; Chan JK; Cho WC; Ma VW; Wan KK; Au SK; Law CK; Lau WH
    Clin Cancer Res; 2002 Apr; 8(4):986-94. PubMed ID: 11948104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A prospective study on relationship between abnormal nasopharyngeal mucosa and nasopharyngeal carcinoma].
    Huang T; Chen D; Huang H
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995; 30(4):216-8. PubMed ID: 8745460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Epstein-Barr virus DNA measurement in plasma in the clinical management of nasopharyngeal carcinoma in a low risk area.
    Kalpoe JS; Dekker PB; van Krieken JH; Baatenburg de Jong RJ; Kroes AC
    J Clin Pathol; 2006 May; 59(5):537-41. PubMed ID: 16489178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent effect of EBV and cigarette smoking on nasopharyngeal carcinoma: a 20-year follow-up study on 9,622 males without family history in Taiwan.
    Hsu WL; Chen JY; Chien YC; Liu MY; You SL; Hsu MM; Yang CS; Chen CJ
    Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1218-26. PubMed ID: 19336547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of cell-free Epstein-Barr virus DNA in monitoring prognosis of nasopharyngeal carcinoma].
    Cao SM; Min HQ; Gao JS; Hong MH; Xiao XB; Zhang CQ; Liu XD; Zhang AL; Guo X
    Ai Zheng; 2003 Mar; 22(3):302-6. PubMed ID: 12654192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow that is positive for Epstein-Barr virus encoded RNA-1 by in situ hybridization is related with a poor prognosis in patients with extranodal natural killer/T-cell lymphoma, nasal type.
    Huang WT; Chang KC; Huang GC; Hsiao JR; Chen HH; Chuang SS; Chen TY; Su WC; Tsao CJ
    Haematologica; 2005 Aug; 90(8):1063-9. PubMed ID: 16079105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of p16 expression has prognostic significance in human nasopharyngeal carcinoma.
    Mäkitie AA; MacMillan C; Ho J; Shi W; Lee A; O'Sullivan B; Payne D; Pintilie M; Cummings B; Waldron J; Warde P; Irish J; Brown D; Gilbert R; Gullane P; Liu FF; Kamel-Reid S
    Clin Cancer Res; 2003 Jun; 9(6):2177-84. PubMed ID: 12796384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of three different serological techniques for primary diagnosis and monitoring of nasopharyngeal carcinoma in two age groups from Tunisia.
    Karray H; Ayadi W; Fki L; Hammami A; Daoud J; Drira MM; Frikha M; Jlidi R; Middeldorp JM
    J Med Virol; 2005 Apr; 75(4):593-602. PubMed ID: 15714486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus serology in early detection and screening of nasopharyngeal carcinoma.
    Ng MH; Chan KH; Ng SP; Zong YS
    Ai Zheng; 2006 Feb; 25(2):250-6. PubMed ID: 16480597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.